Multicenter surveillance of streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era

Sheldon L. Kaplan, Kimberly J. Center, William J. Barson, Philana Ling-Lin, José R. Romero, John S. Bradley, Tina Q. Tan, Jill A. Hoffman, Timothy R. Peters, Alejandra Gurtman, Daniel A. Scott, James Trammel, William C. Gruber, Kristina G. Hulten, Edward O. Mason

Research output: Contribution to journalArticle

43 Scopus citations

Abstract

Background. Streptococcus pneumoniae is a common cause of otitis media (OM) in children; mastoiditis remains an important complication of OM. Limited data are available on the impact of the 13-valent pneumococcal conjugate vaccine (PCV13) on pneumococcal otitis. Methods. Investigators from 8 children's hospitals in the United States prospectively collected pneumococcal isolates from middle ear or mastoid cultures from children from 2011 to 2013. Serotype and antibiotic susceptibilities were determined and PCV13 doses for children documented. Results. Over the 3-year period, the proportion of isolates included in PCV13 (plus a related serotype) decreased significantly (P =. 0006) among the middle ear/mastoid isolates (2011, 50% [74/149]; 2012, 40.5% [47/116]; 2013, 29% [34/118]). The number of serotype 19A isolates in 2013 (n = 12, 10.2% of total) decreased 76% compared with the number of 19A isolates in 2011 (n = 50, 33.6% of total). Of the children from whom serotype 19A was isolated (n = 93), 55% had previously received <3 doses of PCV13. The most common non-PCV13 serotypes for the combined years were 35B (n = 37), 21 (n = 20), 23B (n = 20), 15B (n = 18), 11 (n = 17), 23A (n = 14), 15A (n = 14), and 15C (n = 14). The proportion of isolates with a penicillin minimal inhibitory concentration >2 μg/mL decreased significantly over the 3 years (2011, 22% [35/154]; 2012, 20% [24/118]; 2013, 10% [12/120]; P <. 02). Conclusions. The number of pneumococcal isolates and the percentage of isolates with high-level penicillin resistance from cultures taken from children with OM or mastoiditis for clinical indications have decreased following PCV13 use, largely related to decreases in serotype 19A isolates.

Original languageEnglish (US)
Pages (from-to)1339-1345
Number of pages7
JournalClinical Infectious Diseases
Volume60
Issue number9
DOIs
StatePublished - May 1 2015

Keywords

  • Conjugate vaccine
  • Streptococcus pneumonia
  • Surveillance

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Multicenter surveillance of streptococcus pneumoniae isolates from middle ear and mastoid cultures in the 13-valent pneumococcal conjugate vaccine era'. Together they form a unique fingerprint.

Cite this